NOAH Compendium

Printed from NOAH Compendium (https://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2024. All Rights Reserved.
Date: Wednesday, May 1, 2024 0:52

Release 2.151
Vetrimoxin® 50 mg/g Premix for medicated feeding stuff for pigs
Species: Pigs
Therapeutic indication: Medicinal feed additives: Antimicrobials and antimicrobials combination
Active ingredient: Amoxicillin Trihydrate
Product:Vetrimoxin® 50 mg/g Premix for medicated feeding stuff for pigs
Product index: Vetrimoxin 50 mg/g Premix
Pig - meat: Meat and Offal: 3 days
Incorporating:
Qualitative and quantitative composition
Each g contains:
Active substance :
Amoxicillin (as trihydrate) 50 mg
Excipients :
Wheat starch qsp 1 g
For the full list of excipients, see Pharmaceutical particulars.
Pharmaceutical form
Premix for medicated feeding stuff. White-ivory homogeneous granules
Clinical particulars
Target species
Pigs (weaned piglets)
Indications for use, specifying the target species
In weaned piglets: in herds where infection has been confirmed; treatment of infections caused by Streptococcus suis susceptible to amoxicillin.
Contraindications
Do not use in cases of hypersensitivity to penicillins, to other β-lactams or to the excipient.
Do not use orally to rabbits, guinea pigs, hamsters and horses since the amoxicillin, like all the aminopenicillins, has adverse impact on caecal microflora population. Do not use in the presence of ß-lactamase-producing bacteria.
Special warnings for each target species
Sick animals may have reduced feed intake and consequently, may require parenterally administered medication instead.
The intake of medicated feed depends on the clinical condition of the animals. In order to obtain the correct dosage the concentration of amoxicillin has to be adjusted accordingly.
Special precautions for use
Special precautions for use in animals
Official, national and regional antimicrobial policies should be taken into account when the product is used.
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria.
Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the amoxicillin and may decrease the effectiveness of the treatment.
The prolonged or repeated use should be avoided by e.g. improving management practices, proper cleaning and disinfection. Particular attention should be paid to improvement of farming practices to avoid any stress condition.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Persons handling this product should avoid inhalation of any dust and contact with skin. Wear either a disposable half-mask respirator conforming to European Standard EN149 or a non-disposable respirator to European Standard to EN140 with filter EN143 when mixing or handling this product.
Rubber gloves should be worn when mixing or handling this product. Hands and exposed skin should be washed thoroughly after use.
Do not smoke, eat or drink while handling the product.
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious.
- Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations.
- Handle this product with great care to avoid exposure, taking all recommended precautions.
- If you develop symptoms following exposure such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing, are more serious symptoms and require urgent medical attention.
Adverse reactions (frequency and seriousness)
In very rare cases, the following adverse reactions may occur:
- Hypersensitivity reactions, the severity varying from skin rash to anaphylactic shock.
- Gastrointestinal symptoms (vomiting, diarrhoea).
- Haematology disturbances and colitis.
Use during pregnancy, lactation or lay
Not applicable.
Interaction with other medicinal products and other forms of interaction
Do not use simultaneously with neomycin since it blocks the absorption of oral penicillins.
Do not use jointly with antibiotics that inhibit the bacterial protein synthesis since they can antagonise the bactericidal action of penicillins.
Amounts to be administered and administration route
For oral administration only after incorporation in feed. In-feed use at the final dose 15 mg amoxicillin/ kg b.w./ day, during 14 consecutive days.
In the case of an altered feed intake (clinical status, weight class, age, environment), adjust the incorporation rate in order to guarantee an intake of 15 mg amoxicillin/kg b.w./day.
According to the recommended dose, the number and animal's weight to be treated, the exact dose of medicinal product to be incorporated in the feed should be calculated using the following formula:
0.3 g of medicinal product X Average bodyweight of treated animals (kg)/day
____________________________________________________________
= kg Vetrimoxin/ton of feed
Daily feed intake (kg)
During the granulation, mixture should not reach a temperature above 60ºC.
Body weight should be evaluated accurately to avoid underdosing.
Feed intake depends on the clinical condition of the animal, thus the concentration in the feed should be adjusted to assure the correct dosage. Mix well to ensure homogeneous distribution.
The medicated feed should be the only source of feed during the 14 days of treatment, which represents the maximum period of treatment with the product.
A manufacturer who is approved to incorporate directly at any concentration, veterinary medicinal products or premixtures containing such products must be responsible for mixing when incorporation is less than 2 kg per tonne for final feed.
Overdose (symptoms, emergency procedures, antidotes), if necessary
In the event of severe allergic reactions stop the treatment and administer corticosteroids and adrenaline.
In other cases administer symptomatic treatment.
Withdrawal period(s)
Meat and offal: 3 days
Pharmacological particulars
Pharmacotherapeutic group: antibacterials for systemic use, penicillins with extended spectrum. ATCvet code: QJ01CA04
Pharmacodynamic properties
Amoxicillin is a ß-lactam bactericidal antibiotic. It inhibits biosynthesis of bacterial cell wall through inhibition of the synthesis of peptidoglycan, rendering cell more fragile and, therefore, unable to support endocellular osmotic pressure and, therefore, subject to lyses.
The main mechanism of bacterial resistance to the amoxicillin is the production of ß-lactamases, enzymes that in this way cause the inactivation of the antibacterial via hydrolysis of the ß-lactam ring obtaining penicilloic acid, stable but inactive compound. Resistance to ß-lactams can be transferred horizontally via plasmids or vertically (genes localized on bacterial chromosome). Cross-resistance between the amoxicillin and other penicillin exists, particularly, with other aminopenicillins (ampicillin).
Pharmacokinetic particulars
In the pig, per os administration has a bioavailability of 47%, reaching the maximum serum concentration of 3 µg/ml one hour after the injection. After the administration per os, the plasma concentration (>2.5 µg/ml) is obtained in 1.5-2 hours. Amoxicillin is well distributed in the entire organism, reaching high concentrations in muscle, liver, gastrointestinal tract and kidney because of low percentage of plasmatic protein binding (17- 20%). It is little distributed in brain and spinal fluids, except when meninges are inflamed.
The metabolism of the amoxicillin is limited to the hydrolysis of the ß-lactam ring, which leads to inactive penicilloic acid liberation (20%). The biotransformation takes place in the liver.
Amoxicillin crosses the placental barrier. It is metabolised to a small extent; it is excreted mainly by the urine, and in smaller proportion by milk and bile (enterohepatic cycle).
Pharmaceutical particulars
List of excipients
Wheat starch, Liquid paraffin.
Major incompatibilities
In the absence of compatibility studies this veterinary medicinal product must not be mixed with other veterinary medicinal products.
Shelf life
Shelf-life of the veterinary medicinal product as packaged for sale: 2 years
Shelf-life after first opening the immediate packaging: 3 months
Shelf-life after incorporation into meal or pelleted feed: 3 months
Special precautions for storage
This veterinary medicinal product does not require any special storage conditions.
Nature and composition of immediate packaging
White 10 or 25 kg polyethylene paper bag
Sewing with paper and white cotton thread closes the bags; a rod is added to the sewing cotton thread.
Not all pack size may be marketed
Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements
Marketing Authorisation Holder (if different from distributor)
Marketing Authorisation Number
UK: Vm 15052/4143
Significant changes
Date of the first authorisation or date of renewal
06 July 2017
Date of revision of the text
October 2022
Any other information
PROHIBITION OF SALE, SUPPLY AND/OR USE
Consideration should be given to official guidance on the incorporation of medicated premixes into final feeds. To be supplied only on veterinary prescription.
Legal category
Legal category: POM-V
GTIN
GTIN description:Vetrimoxin 50 mg/g Premix 25 kg
GTIN:03411112938148